MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
14.20
-0.37
-2.54%
Pre Market: 13.80 -0.4 -2.82% 04:00 10/05 EDT
OPEN
14.31
PREV CLOSE
14.57
HIGH
14.34
LOW
14.10
VOLUME
1
TURNOVER
0
52 WEEK HIGH
16.40
52 WEEK LOW
9.77
MARKET CAP
2.48B
P/E (TTM)
137.60
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HCM last week (0928-1002)?
Weekly Report · 6h ago
Hutchmed Advances HMPL-A830 Trial, Keeping Oncology Pipeline – And Investor Interest – Alive
TipRanks · 3d ago
AstraZeneca submits NDA for savolitinib + Tagrisso for NSCLC
Seeking Alpha · 5d ago
Reported Earlier, HUTCHMED Announces AstraZeneca Submitted US NDA For ORPATHYS Plus TAGRISSO In MET-Driven EGFR-Mutated NSCLC, Supported By Phase III SAFFRON Trial
Benzinga · 6d ago
HUTCHMED Seeks FDA Approval For ORPATHYS-TAGRISSO In Resistant Lung Cancer
NASDAQ · 6d ago
Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC
TipRanks · 6d ago
Weekly Report: what happened at HCM last week (0921-0925)?
Weekly Report · 09/28 09:58
HUTCHMED Starts Global Phase 1 Trial Of KRAS-EGFR Therapy HMPL-A830 In Solid Tumors
NASDAQ · 09/28 03:07
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.